Oscar Health 4Q Revenue Rises, Eyes Profitability This Year

Dow Jones
02/10

Oscar Health's fourth-quarter loss widened as the health insurer continued to struggle with the high utilization of medical services by plan enrollees, but revenue rose and the company continues to target profitability this year.

The health insurer, which focuses on individuals and small businesses, posted a loss of $352.6 million, or $1.24 a share, wider than the $153.5 million, or 62 cents a share, reported a year earlier.

On average, analysts had anticipated a loss of 89 cents a share, as per FactSet.

Fourth-quarter revenue rose 17% to $2.81 billion, short of the mean analyst estimate of $3.11 billion.

Oscar's medical loss ratio, a measure of the proportion of premiums that the insurer pays out on medical bills, rose sharply to 95.4%, well in excess of the average analyst target of 91.1%. The company's medical loss ratio in the year-earlier period came in at 88.1%.

The company had around 2 million members as of June 30, up from 1.68 million in the prior year.

Shares recently climbed 12% in morning trading Tuesday.

For 2026, Oscar targeted earnings from operations in a range between $250 million and $450 million on revenue between $18.7 billion and $19 billion.

For the year, Oscar anticipates a medical loss ratio between 82.4% and 83.4%.

"2025 was a reset year for the individual market, and we took decisive actions to return to profitability in 2026," said Oscar Health Chief Executive Officer Mark Bertolini.

Many large health insurers, including UnitedHeath Group, have struggled with rising medical loss ratios in recent quarters as the U.S. population ages and visits to medical facilities increase.

Separately, Oscar Health said it has entered into a $475 million secured, three-year revolving credit facility. The company said it plans to use the proceeds for general corporate purposes.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10